Stents Market Future Scope, Revenue, Top Trends, Growth Opportunity & Regional Outlook 2021-2026

Stents Market Future Scope, Revenue, Top Trends, Growth Opportunity & Regional Outlook 2021-2026

The burgeoning number of peripheral and coronary artery surgical procedures across the world is a key factor expected to accelerate the stents market over the forecast period. In recent years, there has been a growing prevalence of cardiovascular diseases worldwide primarily due to the adoption of a sedentary and unhealthy lifestyle. In fact, reliable reports cite that around 60% of adult Americans are physically inactive. This has led to an increase in the demand for cardiovascular treatments, predominantly accelerating the demand for stents recently.

In addition, a growing elderly population base that needs PCI (Peripheral Coronary Intervention) procedures for the treatment of blockage is expected to further accelerate market growth over the forecast period.

Request for a sample copy of this report @

A study conducted at GMI Inc. suggests that the stents market size is expected to surpass USD 14.3 billion by 2026.

In recent years, industry participants are investing heavily in research and development activities. They are integrating several technologies for developing innovative stents. Citing an instance to highlight the same, in Sept. 2019, OrbusNeich Medical K.K. launched its COMBO Plus Coronary Stent in Japan. The product combines the abluminal sirolimus drug elution distributed from a biodegradable matrix polymer with the proprietary EPC (Endothelial Progenitor Cell) technology.

The company developed this product to address the risk of stent thrombosis related to delayed healing found with traditional drug-eluting stents. With the advent of such products with minimal re-obstruction rate, it comes as no surprise that the stents market will record lucrative growth over the forecast period. Notably, companies such as Meril Life Sciences, Elixir Medical Corporation, Biotronik, Biosensors International Group, Terumo, Boston Scientific, Medtronic, MicroPort Scientific Corporation, B. Braun Melsungen AG, and Abbott Laboratories are currently at the forefront of the stents market.

Vascular stents are gaining increasing demand for the treatment of cardiovascular diseases in recent years owing to the increasing number of CVD patients. In fact, according to European Heart Network, such disorders affected over 85 million Europeans. On this note, the vascular stents segment, which recorded USD 10.3 billion in revenue in 2019, is expected to register lucrative growth over the forecast period.

Meanwhile, industry participants are preferring polymer materials to manufacture vascular stents owing to their high compatibility and fewer post-surgical complications. Studies suggest that the polymer stent segment is expected to surpass USD 3 billion by 2026.


On the regional front, China stents market is expected to offer lucrative growth opportunities on the account of the growing prevalence of CVDs in the nation. In fact, reliable reports cite that cardiovascular diseases accounted for 2 in 5 deaths in China. Companies operating in the region are also focusing on developing innovative products and levering inorganic and organic growth strategies to tap maximum regional share, predominantly accelerating regional industry share. On this note, it is expected that China stents market will record a 5.5% CAGR over the forecast period.

Request for Customization @